Abstracts and Awards - Resuscitation Science Symposium 2024

2024 Resuscitation Science Symposium Abstracts

Deadline

General Abstract Submission is now closed. Late-Breaking Resuscitation Abstract Submission opens June 24.

  1. Airway Management/Ventilation
  2. Basic Science
  3. Biomarkers
  4. CPR
  5. Defibrillation
  6. ECPR/ECMO
  7. Epidemiology
  8. Family, Partner and Rescuer Impact - NEW!
  9. Health Equity
  10. In-Hospital Cardiac Arrest
  11. Intra-Arrest Management
  12. Monitoring
  13. Outcome Predictions/Risk Stratification/Artificial Intelligence
  14. Patient Survivorship and Recovery
  15. Peri/Post Arrest Shock
  16. Post-Arrest Critical Care Cardiology - NEW!
  17. Post-Arrest Intensive Care - NEW!
  18. Post Arrest Neurocritical Care - NEW!
  19. Pre-Hospital/EMS
  20. Prevention/Early Detection - NEW!
  21. Resuscitation Devices
  22. Resuscitation Guidelines
  23. Temperature Control
  24. Training/Education
  25. Translational and Preclinical Science

Overall Abstract Submission Requirements

  • All abstracts must be submitted (and if accepted, will be presented) in English having accurate grammar and spelling suitable for publication.
  • Statistical results (including descriptive and inferential statistics) are to be included.
  • Author must affirm the work submitted is original and all statements declared as facts are based on thorough examination and investigation for accurateness.
  • Authors should not "split" statistical data to create several abstracts from one study. If splitting is judged to have occurred, prior scores of related abstracts will be negatively influenced.
  • Abstracts containing identical or nearly identical data submitted from the same institution and/or individuals will be disqualified.
  • Proofread abstracts carefully to avoid errors before the submission deadline. The abstract will be published exactly as it has been submitted.
  • Submission of an abstract constitutes a commitment by the author(s) to present if accepted. Failure to present, if not justified, will jeopardize future acceptance of abstracts for American Heart Association meetings/conferences.
  • There is no limit to the number of abstracts an investigator may submit. If selected, the presenter must be one of the co-authors listed. If multiple submissions are accepted, the presenting author must resolve schedule conflicts by arranging for a co-author to present.
  • Abstracts associated with a published manuscript can be presented at an AHA scientific event if the manuscript was published after the time the abstract was submitted to the event, however the abstract will not be published as a part of the journal publication.

Abstract Title

  • An abstract must have a short, specific title (containing no abbreviations or inflammatory language) that indicates the nature of the investigation.
  • Avoid an abstract title that reveals the results of the study. Explicit titles denoting the findings should be used (not "Investigations of…," "Studies of…," etc.)

Abstract Text

  • It is recommended abstracts have the following identifiable sections:
    • Introduction/Background
    • Research Questions/Hypothesis
    • Goals/Aims
    • Methods/Approach
    • Results/Data (descriptive and inferential statistics)
    • Conclusion(s)
  • Looking for recommendations on how to improve your abstract? We highly recommend you view these recommendations from AHA journals.
  • Use generic drug names.
  • Avoid beginning sentences with numbers.
  • Standard abbreviations may be used without definition. Nonstandard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated.
  • Do not include references, credits or grant support.
  • Do not include the names or personal information of any patient participating in the study or trial.

  • Abstract Character Guidelines:
    • Abstracts are limited to 2,500 characters (about 400 words).
    • Spaces and punctuation count as characters.

  • Graphics Guidelines:
    • You may submit a maximum of up to 3 images.
    • All graphics (figures) and text-based graphics (tables) should be provided as 72-300 dpi, pre-sized .BMP, .GIF, .JPG or .PNG images only, with a maximum width of 440 pixels (no limit on length). Black-and-white digital images should be in grayscale mode. Color images should be saved in RGB color mode.
    • All graphics will require a brief description of the image (alt text).
    • Please Note: If an abstract is accepted for publication, any images submitted with the abstract are placed after the abstract that will appear in the online-only supplement to Circulation, an American Heart Association journal.

Author Name(s)

  • The submitting author will be designated as the primary and presenting author unless otherwise specified. The presenting author must be listed on the abstract and can be listed anywhere in the author block.
  • Please review the author block carefully. Edits cannot be made after the June 10, 2024 at 7:00 p.m. EDT (UTC -5) deadline. Once submission is complete, the author block will be published as submitted. Additions or deletions of author names are not permitted after the submission deadline.

Abstract Revisions

  • After the June 10, 2024 at 7:00 p.m. EDT (UTC - 5) deadline, your abstract submission is considered final and cannot be edited.
  • Abstracts may not be revised in any way or resubmitted.
  • Additions or deletions of author names will not be permitted.
  • Proofread abstracts carefully to avoid errors before submission.

Abstract Copyright Transfer Agreement

  • Abstract Copyright Transfer Agreement will be electronically signed during submission.
  • Your selection of "Yes" will grant permission to publish.
  • Your selection of "No" will prohibit publication of the abstract in all formats including the Circulation supplement, ePoster site, and the online program planner.

Abstract Review

  • Abstracts successfully submitted by the June 10, 2024 at 7:00 p.m. EDT (UTC -5) deadline are posted to a secured web site for blind review. Our intent is to be inclusive of quality science received without compromising scientific integrity. As such, a team of experts, selected by the ReSS Program Committee, independently reviews abstracts in the category that best fits their expertise.
  • Abstracts submitted for consideration must convey an original idea, concept, or an improvement or revision of a previous idea. Abstracts are selected on the basis of the following:
    • Scientific merit – direction toward the development of a new or improved diagnostic procedure or idea.
    • Organization – well organized, easy to follow and understand.
    • Practicality – should be available, logical and feasible.
    • Presentation – should be clear, brief, show understanding of the subject matter.
    • Technical quality – the idea must stand up to scrutiny. Facts and data have scientific backing.

Abstract Acceptance

  • Abstract acceptance/non-acceptance status will be available by mid-September. Please ensure the email provided for the presenting author is accurate as all correspondence will be sent via email, to the presenting author only.
  • All communications regarding your abstract will be sent from [email protected]. Please make sure to add this email address to your email contacts to ensure important program participant related information gets through your spam filters, etc.
  • All accepted abstracts will be scheduled either in an oral or poster presentation format. All presentations including question-and-answers will be conducted in English. Presenters may request assistance from the moderator who will repeat or rephrase questions from the audience or may ask a colleague in the audience to assist with translation.
  • Guidelines for abstract presentation will be included in the acceptance communication.

Abstract Journal Publication

  • Accepted abstracts having selected “Yes” to the Abstract Copyright Transfer Agreement will be published online in the Circulation journal supplement.

Embargo Policy

  • Non-late breaking abstracts and presentations are embargoed for release at date and time of presentation for oral abstract presentations; and November 16, 2024, at 8:00 am Central Time for all poster presentations, and are therefore prohibited from release until date and time of AHA designated embargo time. You will be contacted by AHA communications if you are selected to participate in an AHA news event.
  • Abstracts and presentations are embargoed for release at 5 a.m. EST, Monday, November 6, 2023, and are therefore prohibited from release until date and time of AHA designated embargo time. You will be contacted by AHA communications if you are selected to participate in an AHA news event.
  • Written embargoed information cannot be shared with anyone outside of the AHA with the exception of a journal manuscript where one-on-one embargoed media interviews can be conducted as long as the reporter agrees to abide by the embargo policy. Failure to honor embargo policies will result in this abstract being withdrawn and future abstracts also being barred from presentation. Complete AHA Embargo Policy.

Recording Policy

  • Unauthorized recording of the AHA Scientific Sessions, scientific conferences, and the AHA/ASA International Stroke Conference is prohibited, whether by video, still or digital photography, audio or any other recording or reproduction mechanism. This includes recording of presentations and supporting audiovisual materials and of poster presentations and supporting poster materials.
  • The American Heart Association and American Stroke Association reserve the rights to all recordings or reproductions of presentations at AHA/ASA scientific conferences and meetings.

Use of Automated Assistive Writing Technologies and Tools

  • The use of automated assistive writing technologies and tools (commonly referred to as artificial intelligence or machine learning tools) is permitted provided that their use is documented, and authors assume responsibility for the content. As with human-generated content, authors are responsible for the accuracy, validity and originality of computer-generated content. Automated assistive writing technologies do not qualify for authorship as they are unable to provide approval or consent for submission.
  • If the use of these technologies has involved the research design, the tools should be documented in the Methods. For additional information, see the World Association of Medical Editor recommendations.
  • For your abstract submission, you will need to indicate the use of these tools.

Download a printable PDF of the Abstract Guidelines, including Revisions, Review and Acceptance. 

2024 ReSS Abstract Guidelines (PDF, 165K)

ReSS Awards

The ReSS Best of the Best Abstract Awards are presented for the top-scoring abstracts submitted to the Resuscitation Science Symposium. To be eligible to receive one of these awards, attendees must have submitted an abstract to ReSS 2024 during the regular submission process that is related to either cardiac or trauma resuscitation science, receive a top score for that abstract and be a member of the American Heart Association.

The ReSS Early Career Investigator Awards will be presented for top-scoring abstracts submitted to the Resuscitation Science Symposium. Awards will be given for abstracts pertaining to both cardiac and trauma resuscitation science. To be eligible to receive one of these awards, young investigators (researchers/clinicians within the first five years of their appointment) must have submitted an abstract to ReSS 2024 during the regular submission process, receive a top score for that abstract and be a member of the American Heart Association.

The Ian G. Jacobs Award for International Group Collaboration to Advance Resuscitation Science recognizes international collaboration among individuals over an extended time that has resulted in major contributions to fundamental or clinical science related to cardiac arrest or traumatic injury.

The Lifetime Achievement Awards in Resuscitation Science were established by the Emergency Cardiovascular Care Committee in 2003 to honor scientists for their outstanding contributions in resuscitation science.


Awards applied for through the Council Awards Application System. Detailed instructions, eligibility requirements, award criteria, and important deadlines for these awards may be found on the individual award pages shown below.

3CPR Emergency Medical Services (EMS) Travel Grant
Sponsored by the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (3CPR), the EMS travel grants allow full-time EMS personnel to attend ReSS (applicants must hold appropriate EMS credentials, at either EMT or paramedic level). The recipients of these travel grants are selected based on their commitment and interest in cardiac arrest, CPR and resuscitation care.


Max Harry Weil Early Career Award Competition for Resuscitation Science
Sponsored by the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (3CPR), this award competition honors the memory of Max Harry Weil, MD, PhD, considered a “father of critical care medicine” and a pioneer in 3CPR science. Finalists will be invited to present their research results at the Resuscitation Science Symposium in November.


Paul Dudley White International Scholar Award
Abstracts submitted to the Resuscitation Science Symposium 2024 may be considered for a Paul Dudley White International Scholar Award. This award recognizes authors who contributed to the highest ranked accepted abstract from each country. You don't have to apply, and professional membership is not required.

The presenting author will be notified of award selection approximately 6 weeks prior to the meeting. Interested in knowing more? Visit the Paul Dudley White International Scholar Award web page.

 

Please Note

The AHA has moved to a single sign-on process for submitting abstracts and disclosures.

Abstract submitters must have a username and password on professional.heart.org to complete their abstract submission when submitting to any AHA scientific meeting.

If you do not remember your Professional Heart Daily login information or need to update your personal profile, do not create a new account. Please reach out to AHA Customer Service for assistance:

AHA Customer Service:
1-888-242-2453 (Inside U.S.)
1-214-570-5935 (Outside U.S.)
Email: [email protected]
Hours of Operation: Monday-Friday (8 a.m. – 5 p.m. CT)

The AHA is now required to collect financial disclosures from all abstract submitting authors and co-authors.  As the submitting author, please be prepared to provide all co-author emails.

Co-authors without a complete disclosure will receive separate correspondence to submit this information.

2023 Award Winners

Lifetime Achievement Award

The AHA Committee on Emergency Cardiovascular Care established the Lifetime Achievement Award in 2003 to honor scientists for their outstanding contributions in cardiac resuscitation science. The 2023 Award for Lifetime Achievement will be presented at 9:45 am on Saturday, November 11th.

Laurie J. Morrison, MD, MSc, FRCPC | University of TorontoThe 2023 Award will be presented to Laurie J. Morrison, MD, MSc, FRCPC. Dr. Morrison is Professor and Clinician Scientist in the Division of Emergency Medicine, Department of Medicine at the University of Toronto and Sunnybrook Health Sciences Centre. Her program of research is focused on the evaluation and implementation of time sensitive interventions in acute emergencies. She established Rescu, a collaborative prehospital research network. Together, the Rescu investigators conducted randomized controlled trials and outcome validation studies in resuscitation research (cardiac arrest and trauma) and contributed to the Resuscitation Outcomes Consortium. She founded the Collaborative Specialization in Resuscitation Sciences enabling the training of over 80 graduate students. Rescu has evolved into a national resuscitation network for Canada (CanROC).

She has published over 300 papers, held over $26M in peer reviewed grants as a principal investigator and has an h index of 71 (web of science). She contributed to the development of the 2005 and 2010 and 2015 AHA Guidelines. She provides scientific oversight of the Continuous Evidence Evaluation strategy for the International Liaison Committee on Resuscitation. She is founding member and current chair of the Network of Canadian Emergency Medicine Researchers. This network provides peer review and mentorship of emerging researchers and support for multicenter trials.

Dr Morrison has received the Canadian Medical Association May Cohen award for excellence in mentorship; was granted honorary membership by the European Resuscitation Council for lifetime achievement in resuscitation sciences in 2017; gave the AHA Dickinson W. Richards Memorial Lecture in 2018 and was named a Giant in Resuscitation by the International Liaison Committee on Resuscitation in 2021.

 

ReSS Champion Award

Katherine Y Brown HeadshotThe ReSS Champion Award recognizes an individual who has demonstrated commitment to the field of resuscitation science, through championing research and/or clinical improvements, supporting resuscitation scholars, and serving as a passionate advocate for our field. This award is designated for an individual who is not a full-time healthcare professional (not a physician, nurse or paramedic) but rather someone who supports our field through their work in government, industry or public advocacy. This year, the award will be presented to Katherine Y. Brown, EdD, on Saturday, November 11th at 9:45 am.

Dr. Brown is the founder of Learn CPR America, LLC where she teaches CPR for individuals and organizations around the world. She has been a dedicated volunteer for the American Heart Association for more than 30 years and is a recognized expert in health disparities and curriculum development. She has traveled all over the world teaching CPR, having trained over a quarter of a million people in this lifesaving skill.

Ian G. Jacobs Award

The Ian G. Jacobs Award for International Group Collaboration to Advance Resuscitation was established in 2010 to recognize international collaboration among individuals over an extended period of time that has resulted in major contributions to fundamental or clinical science related to cardiac arrest or traumatic injury.

The 2023 award will be presented to the Sudden Cardiac Arrest UK Peer Support Group, a national initiative that builds on survivorship science by Dr. Thomas Keeble and others.  Survivorship has growing importance in resuscitation science and this group has developed important infrastructure to support survivors and families that serves as a role model for global efforts towards improved quality of life after cardiac arrest.  The award will be presented at 10:10 am on Saturday, November 11.

2023 ReSS Best of the Best Abstract Awards

Four recipients have been selected to receive this award for the top-scoring abstracts submitted to the Resuscitation Science Symposium. The winners of the Best Abstract Awards will be recognized during the Best of the Best Oral Abstract Presentations at Saturday, November 11, 2023 at 11:00 a.m. - 12:00 p.m.

Rasmus Paulin Beske, MD | Copenhagen University Hospital
Rasmus Paulin Beske, MD | Copenhagen University Hospital
Abstract Presentation #100, Blood Pressure Targets and Hemodynamics According to Initial Blood Lactate Levels in Patients with Comatose Out-of-hospital Cardiac Arrest - A Substudy of The Box Trial
Laust Obling Headshot

Laust E.R. Obling, MD | Rigshospitalet
Abstract Presentation #101, Prehospital High-dose Methylprednisolone Treatment Reduces Norepinephrine Need Following Resuscitated Out-of-hospital Cardiac Arrest

Amanda J O'Halloran

Amanda J. O’Halloran, MD | Children’s Hospital of Philadelphia
Abstract Presentation #102, Early Bolus Epinephrine Administration During Pediatric Cardiopulmonary Resuscitation For Bradycardia With Poor Perfusion

Jung A Yoon, MD

Jung A Yoon, MD| Chungnam Nat'l University Hospital
Abstract Presentation #103, Quantitative Analysis Of Apparent Diffusion Coefficients To Predict Neurological Prognosis In Cardiac Arrest Survivors: An Observational Derivation And Internal-external Validation Study

ReSS Early Career Travel Award

These awards are presented for the top-scoring abstracts submitted by young investigators within the first five years of their appointment. The Young Investigator Event will recognize the following winners of these awards on Friday, Nov. 10.

 Awardee Presentation Number Abstract Title
 Dieter Bender, PhD  104  Photoplethysmogram Signal Characteristics as a Non-Invasive Surrogate of Diastolic Blood Pressure During Cardiopulmonary Resuscitation
 Jason Coult, PhD 219  Prediction of Shock-refractory Ventricular Fibrillation Amidst Continuous Chest Compressions During Out-of-hospital Cardiac Arrest Resuscitation
 Jakob Josiassen, MD, PhD 187  Diabetes is Associated with Mortality Among Comatose Survivors of Cardiac Arrest but Does not Interact With Blood-pressure Targets
 Martin A.S. Meyer, MD, PhD 139  Targeted Blood Pressure, Oxygenation, and Duration of Device-based Fever Prevention After Out-of-hospital Cardiac Arrest - Effects on 1 Year Survival
 Helen N. Palatinus, DO 107  Accelerated Intramuscular Epinephrine and Survival in Adult, Non-Traumatic Out-of-Hospital Cardiac Arrest: A Before-After Study
 Alexander M. Presciutti, PhD 287  Psychosocial and Functional Status are Associated with Readiness for Hospital Discharge Among Cardiac Arrest Survivors
 Nelly Carolina C. Rojas-Salvador, MD 110   Brain Injury Biomarkers are Associated with Poor Neurological Outcomes Within 24 Hours After Refractory VT/VF Cardiac Arrest Requiring Extracorporeal Cardiopulmonary Resuscitation
 Morgan B. Swanson, MD, PhD 394  Epinephrine Administration Before Defibrillation in Children with an Initially Shockable In-hospital Cardiac Arrest Rhythm
 Rose T. Yin, PhD 189  How Quickly Does Arterial Blood Pressure Recover After Pauses in Mechanical Chest Compressions in Humans with Out-of-hospital Cardiac Arrest?
 Yeonho You, MD 149   The Effect of Lumbar Cerebrospinal Fluid Drainage on Mortality Reduction and Neuro-prognostic Improvement in Out of Hospital Cardiac Arrest Patients Underwent Targeted Temperature Management